Back to search

Agricultural University of Athens

Μελέτη του παθοφυσιολογικού ρόλου της πρωτεΐνης RANKL στον μαστικό αδένα διαγονιδιακών ποντικών

Abstract

dc:description

Breast cancer is the second most common cancer worldwide and the primary cause of death in women. RANKL (Receptor Activator of Nuclear Factor κB Ligand) has been identified as the main mediator of mammary gland development by progesterone during pregnancy, and recent data implicate it in hormone-induced breast cancer. This doctoral thesis focuses on studying the role of RANKL in the physiological development of the mammary gland, as well as in the development and progression of breast cancer, using unique genetic mouse models of RANKL overexpression (TgRANKL) or inactivation (RANKLtles/tles). More specifically, the objectives of this doctoral thesis aimed to: a) Develop a three-dimensional imaging and quantification method for mouse mammary glands; b) Investigate the effect of RANKL overexpression in the structure of the mammary epithelium at various developmental and reproductive stages in mice, including adolescence, maturity, pregnancy, and lactation; c) Study the molecular and cellular mechanisms involved in the increased mammary gland density in TgRANKL mice; d) Analyze the effect of RANKL absence or inhibition in the early stages of mammary epithelium formation; e) Understand the role of RANKL in hormone-induced breast cancer; f) Create a humanized humTgRANKL genetic mouse model to study hormone-induced carcinogenesis exclusively through huRANKL and to perform preclinical trials with the huRANKL inhibitor Denosumab; g) Identify the network of genes that are deregulated during hormone-induced carcinogenesis in the humTgRANKL model and assess the impact of Denosumab on their expression. Initially, we developed a new method for three-dimensional imaging and quantification of the mammary gland with high resolution through staining with phosphotungstic acid (PTA) and analysis via micro-computed tomography (microCT). Subsequently, we studied the morphology of the mammary gland of TgRANKL mice at the mature stage with carmine staining, microCT, and histological analysis, demonstrating that TgRANKL mice develop increased density in the network of mammary ducts, especially secondary and tertiary branches when compared to wild-type (WT) mice. Expression analysis revealed overexpression of the huRANKL gene in the mammary glands of TgRANKL mice, and localization of the protein at the luminal epithelial cells. Moreover, the expression of genes related to the proliferation of epithelial cells and mammary stem cells was also found upregulated. Flow cytometry analysis showed an increase in luminal epithelial cells and mammary stem cells (MRU) in the mammary glands of TgRANKL mice. The decrease of mammary epithelial density and proliferation markers in TgRANKL mice treated with the monoclonal antibody Denosumab, an inhibitor of huRANKL, confirmed the role of the transgene in this phenotype. Comparative expression analysis in mature mammary glands between TgRANKL and WT mice through RNA sequencing (RNA-Seq) demonstrated that the overexpression of huRANKL induces the activation of signaling pathways and genes related to development, proliferation, metabolism, hormone signaling, and cancer. This was further validated by the expression of selected genes using qPCR. During pregnancy and lactation, TgRANKL mice also exhibited more extensive development of alveoli. In adolescence, TgRANKL mice showed faster development of mammary epithelium and an increase in terminal end buds (TEBs) compared to WT mice. However, the absence of RANKL inhibits mammary gland development, both in a genetic mouse model and through pharmacological inhibition of RANKL. Furthermore, the overexpression of huRANKL in TgRANKL mice did not affect the development and characteristics of hormone-induced (MPA/DMBA) tumors compared to WT mice. However, the inhibition of RANKL with OPG-Fc reduced both the frequency and the number of tumors per mouse. Subsequently, we created a humanized transgenic model (humTgRANKL) to study hormone-induced carcinogenesis exclusively through huRANKL. The humTgRANKL mice developed tumors to the same extent as TgRANKL and WT mice. Prophylactic treatment of humTgRANKL mice with Denosumab inhibited tumor formation in the mammary gland, as well as early stages of carcinogenesis. This highlights the importance of RANKL, especially in the early stages of oncogenesis. Finally, we identified the network of genes that are deregulated during hormone-induced carcinogenesis in humTgRANKL mice and assessed the impact of prophylactic treatment with Denosumab on their expression through RNA-Seq analysis in adjacent mammary glands. Our results revealed a plethora of genes involved in breast cancer processes and pathways induced by RANKL signaling. Overall, our findings emphasize the significance of RANKL in the physiological development of the mammary epithelium at various developmental stages as well as its crucial role in hormone-induced carcinogenesis. The discovery of deregulated genes during carcinogenesis and the evaluation of new drugs against hormone-induced breast cancer in humTgRANKL mice could contribute to the understanding of carcinogenesis mechanisms and the development of targeted preclinical trials in breast cancer.

Degree

thesis:*
Grantor dc:publisher
Agricultural University of Athens
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kolokotroni, Anthi
  • Κολοκοτρώνη, Ανθή

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54905

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kolokotroni, Anthi; Κολοκοτρώνη, Ανθή. Μελέτη του παθοφυσιολογικού ρόλου της πρωτεΐνης RANKL στον μαστικό αδένα διαγονιδιακών ποντικών. Agricultural University of Athens, 2023. http://hdl.handle.net/10442/hedi/54905